Nathalie M Schmidt

6PUBLICATIONS
71CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 25, 2023
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS.

Laura J Pallett, Leo Swadling, Mariana Diniz

|Mar 17, 2022
Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma.

Nekisa Zakeri, Andrew Hall, Leo Swadling

|Nov 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

Leo Swadling, Mariana O Diniz, Nathalie M Schmidt

|May 15, 2021
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.

Nathalie M Schmidt, Peter A C Wing, Mariana O Diniz

|Dec 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

Catherine J Reynolds, Leo Swadling, Joseph M Gibbons

|Oct 13, 2020
Cholesterol-modifying drugs in COVID-19.

Nathalie M Schmidt, Peter A C Wing, Jane A McKeating

Pageof 1